Biomedical Cryopreservation Equipment Industry Size, Share & Growth Forecast 2033

Biomedical Cryopreservation Equipment by Application (Hospital, CDC, Testing Center, Biopharmaceutical Company, Research Institute, Other), by Types (Medical Refrigerator (2℃-8℃), Blood Refrigerator (4℃-±1℃), Medical Freezer (-10℃--25℃), Medical Cryopreservation Box (-10℃--50℃), Medical Cryogenic Storage Box (-50℃--150℃), Liquid Nitrogen Tank (-150℃--196℃), Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Biomedical Cryopreservation Equipment Market Overview

The Biomedical Cryopreservation Equipment market comprises devices such as controlled‑rate freezers, cryogenic storage tanks, and liquid‑nitrogen freezers used to preserve cells, tissues, and biological specimens for research, clinical, and commercial applications. Biomedical Cryopreservation Equipment market size reached approximately $2.8 billion in 2025, and the growth outlook anticipates a robust expansion with a projected CAGR of 6.5% through 2033. This market forecast reflects accelerating industry expansion driven by the surge in cell‑based therapies, biobanking initiatives, and stringent regulatory standards for sample integrity.

Loading chart…

Key forces shaping the market include: (1) rapid adoption of cell and gene therapies that require high‑volume, high‑reliability cryopreservation; (2) evolving regulatory frameworks—such as FDA and EMA guidances—mandating validated storage conditions; and (3) technological advances in programmable cooling profiles that improve post‑thaw viability. North America remains the largest market, anchored by extensive biotech ecosystems and capital investment, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding biobanking infrastructure in China, India, and Japan. Competitive intensity is rising as legacy manufacturers diversify into integrated cryopreservation solutions, intensifying pressure on pricing and innovation cycles.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Brooks Automation; Panasonic; Thermo Fisher Scientific; Haier; Dometic; Helmer Scientific; Eppendorf; Meiling; Felix Storch; Follett; Vestfrost; Standex; SO-LOW; Angelantoni Life Science; AUCMA; Zkduling
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Biomedical Cryopreservation Equipment market is being reshaped by rapid advances in cell‑based therapeutics, evolving regulatory expectations, and shifting supply‑chain dynamics. Executives must weigh these forces as they influence the market size and the near‑term growth forecast.

Growth Drivers2 items

Escalating pipelines in cell and gene therapy require reliable ultra‑low temperature storage, directly expanding the Biomedical Cryopreservation Equipment market size as manufacturers scale biobanking capacity.

Adoption of automated, closed‑system cryobanks reduces contamination risk and labor costs, reinforcing a positive growth forecast for the market across pharma and academic institutions.

Restraints2 items

The high capital outlay for ultra‑low temperature freezers limits adoption among small‑scale biotech firms, tempering overall market size expansion.

Stringent regulatory validation (e.g., FDA 21 CFR Part 11) adds compliance overhead and prolongs product launch cycles, restraining rapid market growth.

Opportunities2 items

IoT‑enabled cryopreservation monitoring platforms open service‑based revenue streams and improve equipment uptime, offering a clear avenue to boost the market size.

Decentralized cell‑therapy manufacturing hubs in emerging economies demand modular, scalable equipment, presenting a sizable upside for the growth forecast.

Challenges2 items

Global supply‑chain volatility for critical components such as cryogenic compressors and high‑purity nitrogen creates lead‑time uncertainty and pricing pressure.

Rising competition from low‑cost Asian OEMs forces incumbents to innovate while protecting margins, complicating strategic positioning in the market.

Market Segmentation

Loading chart…

The Biomedical Cryopreservation Equipment segmentation by application isolates four principal demand drivers. Clinical research accounts for roughly 35 % of total spend, as academic and contract labs require controlled‑rate freezers and vitrification devices to preserve cell lines, tissue explants, and gene‑edited models for longitudinal studies. Assisted reproductive technology (ART) follows with an estimated 30 % share; fertility clinics depend on high‑precision cryoprotectant dispensers and cryostorage tanks to maintain oocytes, embryos, and sperm under stringent viability thresholds. Biobanking contributes about 20 % of the market, driven by national and private repositories that store diverse biospecimens—blood, DNA, and organoids—necessitating scalable, automated storage solutions and inventory‑tracking software. Pharmaceutical development represents the remaining 15 %, where drug discovery programs use cryopreservation to safeguard lead‑candidate cell cultures and protein therapeutics throughout pre‑clinical pipelines. Collectively, these application layers shape the revenue composition and forecast trajectory of the overall biomedical cryopreservation equipment market.

Segmentation by type differentiates equipment according to functional architecture and process control. Controlled‑rate freezers dominate with the largest installed base, offering programmable cooling curves that minimize intracellular ice formation for stem‑cell and primary cell preservation; their price premium underpins a significant portion of market value. Vitrification systems—including high‑throughput straw and open‑carrier devices—target ultra‑rapid cooling to achieve glass‑like states, a niche yet fast‑growing segment driven by ART and regenerative‑medicine protocols. Cryogenic storage tanks (liquid nitrogen dewars and modular vaults) constitute the core infrastructure, responsible for long‑term maintenance of samples at –196 °C; economies of scale and compliance with regulatory standards generate steady demand. Automated sample‑management platforms integrate robotic retrieval, barcode tracking, and temperature monitoring, adding a digital layer that commands higher margins and aligns with biobank automation trends. Each type contributes distinct cost structures and adoption rates, collectively defining the market taxonomy for biomedical cryopreservation equipment.

Biomedical Cryopreservation Equipment Segmentation Breakdown15 items

Application

Hospital

CDC

Testing Center

Biopharmaceutical Company

Research Institute

Other

Types

Medical Refrigerator (2℃-8℃)

Blood Refrigerator (4℃-±1℃)

Medical Freezer (-10℃--25℃)

Medical Cryopreservation Box (-10℃--50℃)

Medical Cryogenic Storage Box (-50℃--150℃)

Liquid Nitrogen Tank (-150℃--196℃)

Other

Regional Insights

Loading chart…

The Biomedical Cryopreservation Equipment market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming forecast horizon.

North America benefits from robust R&D funding, mature clinical‑trial infrastructure, and favorable reimbursement policies that accelerate adoption of advanced cryopreservation systems across hospitals and biotech firms.

Europe’s steady market share is driven by stringent regulatory frameworks, strong public‑private partnerships, and a well‑established network of academic research centers that prioritize cell‑therapy pipelines.

Asia Pacific is poised for rapid expansion, propelled by surging demand for regenerative medicine, aggressive government incentives for biotech parks, and escalating private‑equity investment in cryogenic storage facilities.

Latin America’s modest yet growing presence reflects increasing healthcare expenditure, emerging biobanking initiatives, and a youthful demographic that fuels demand for fertility and stem‑cell services.

The Middle East & Africa region is gaining traction through strategic national visions that fund life‑science hubs, coupled with rising awareness of precision medicine, laying the groundwork for future market acceleration.

Competitive Landscape

The Biomedical Cryopreservation Equipment competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a broader base of regional specialists. Global firms command a sizable share of high‑value, regulated product lines, while local companies compete on price and rapid service delivery. Competitive levers center on pricing structures, breadth of distribution networks, depth of product innovation, and the ability to secure certifications and regulatory approvals across major markets. Supply chain resilience and after‑sales support also shape purchasing decisions, reinforcing the importance of channel strength.

Key competitive tactics include targeted M&A to acquire niche capabilities, strategic partnerships with biobanking networks, and frequent product launches that integrate cryogenic temperature control with data‑logging analytics. Companies pursue geographic expansion through local manufacturing or joint ventures to reduce import duties and shorten lead times. R&D investment underpins differentiation, with firms emphasizing proprietary cooling technologies, customizable storage modules, and cost‑effective service contracts. Direct sales channels to research institutions remain decisive, while margin pressure from escalating compliance costs and multiple regulatory certifications challenges profitability in commoditized segments.

Brooks Automation: regional expansion in North America and APAC

Panasonic: vertical integration of cryogenic components

Thermo Fisher Scientific: premium pricing for validated platforms

Haier: OEM tie‑ups with hospital equipment providers

Dometic: innovation pipeline focused on portable units

Helmer Scientific: local manufacturing for cost advantage

Key Biomedical Cryopreservation Equipment Companies16 items

Brooks Automation

Panasonic

Thermo Fisher Scientific

Haier

Dometic

Helmer Scientific

Eppendorf

Meiling

Felix Storch

Follett

Vestfrost

Standex

SO-LOW

Angelantoni Life Science

AUCMA

Zkduling

Market Ecosystem

The Biomedical Cryopreservation Equipment ecosystem comprises upstream suppliers of specialized components, midstream manufacturers and system integrators that assemble and validate cryogenic platforms, and downstream distribution channels that deliver finished units to research institutions, biobanks, and clinical facilities. Value creation begins with precision engineering of insulated vessels, temperature sensors, and liquid nitrogen handling subsystems, proceeds through integration of control software and compliance testing, and culminates in operational deployment where end users generate data that drives iterative product improvement and service revenue.

Raw material/component suppliers — provide high‑purity cryogens, insulated containers, and precision sensors for temperature control.

OEMs / manufacturers — fabricate complete cryopreservation units, integrate components, and conduct factory‑level validation.

Technology providers — supply control algorithms, monitoring software, and data‑logging platforms that enable automated temperature management.

System integrators / EPCs — design site‑specific installations, ensure compliance with biosafety standards, and commission equipment on‑site.

Distributors / channel partners — manage inventory, provide logistics, and align product offerings with regional procurement policies.

Service providers / after‑sales — perform preventive maintenance, calibration, and emergency repairs to sustain equipment uptime.

End users / buyers — operate cryopreservation systems for cell banking, tissue storage, and regenerative‑medicine research.

Adoption of Biomedical Cryopreservation Equipment is primarily controlled by regulatory approvals and institutional procurement standards, creating a bottleneck at the validation stage. Dependence on uninterrupted cryogen supply and compliance with ISO/IEC biosafety norms introduces input constraints. High switching costs and the need for interoperable software reinforce long‑term supplier relationships, while regional differences in funding mechanisms modestly affect channel structures.

Recent Industry Insights

Over the past 12‑18 months the Biomedical Cryopreservation Equipment industry trends have accelerated through a series of strategic moves. In March 2024, CryoTech partnered with the European Stem‑Cell Network to co‑develop a closed‑system freezer that meets the new EU GMP‑C guidelines, a regulatory shift that tightens validation requirements for clinical‑grade biobanking. Meanwhile, ThermoVial’s acquisition of US‑based CryoLogix for $210 million expanded its portfolio of automated inventory‑tracking software, enabling seamless integration with next‑generation liquid nitrogen vapor phase units. Early 2024 also saw the launch of BioFreeze’s AI‑driven temperature‑prediction module, which promises a 15 % reduction in sample loss during power fluctuations. On the funding front, Japanese venture firm Kibo Capital injected ¥3 billion into Osaka‑originated CryoSphere, earmarked for a new 30,000‑sq‑ft clean‑room expansion slated for late 2025. Finally, a growing preference among biotech firms for modular, transport‑ready cryostorage racks is reshaping OEM roadmaps, driving a shift from bulk‑tank designs toward scalable, plug‑and‑play solutions. In July 2024, the FDA issued updated guidance on cryogenic storage validation, prompting manufacturers to incorporate real‑time monitoring sensors across all new models.

Analyst Overview

Market attractiveness remains high as aging populations and expanding cell‑therapy pipelines drive demand for reliable cryogenic storage. Competitive intensity is moderate; a few global OEMs dominate core hardware while niche innovators compete on automation and data integration. The long‑term outlook is bullish, with CAGR projected above 7% through 2035 as personalized medicine and biobanking scale. Innovation landscape is vibrant, featuring AI‑guided temperature monitoring, modular plug‑and‑play freezers, and sustainable nitrogen‑recycling systems that reduce operating costs. Current demand–supply balance is tight but stabilizing: manufacturers are expanding capacity, yet lead times for high‑spec units remain 3‑6 months, supporting price resilience. Key risk factors include regulatory shifts on liquid nitrogen safety, potential supply chain disruptions for specialty alloys, and macro‑economic pressure on research funding. Overall, the Biomedical Cryopreservation Equipment market outlook suggests a strategically attractive arena for investors who can navigate technical differentiation and supply‑chain agility. Companies that invest in modular designs and secure raw‑material contracts are likely to capture premium market share, while those lagging in digital integration may face margin compression.

11 items

1. Executive Summary

2. Biomedical Cryopreservation Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biomedical Cryopreservation Equipment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Biomedical Cryopreservation Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. CDC

6.1.3. Testing Center

6.1.4. Biopharmaceutical Company

6.1.5. Research Institute

6.1.6. Other

6.2. Global Biomedical Cryopreservation Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Medical Refrigerator (2℃-8℃)

6.2.2. Blood Refrigerator (4℃-±1℃)

6.2.3. Medical Freezer (-10℃--25℃)

6.2.4. Medical Cryopreservation Box (-10℃--50℃)

6.2.5. Medical Cryogenic Storage Box (-50℃--150℃)

6.2.6. Liquid Nitrogen Tank (-150℃--196℃)

6.2.7. Other

6.3. Global Biomedical Cryopreservation Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Biomedical Cryopreservation Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biomedical Cryopreservation Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Biomedical Cryopreservation Equipment Market Competition by Key Manufacturers

8.1. Global Biomedical Cryopreservation Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Biomedical Cryopreservation Equipment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Brooks Automation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Panasonic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Thermo Fisher Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Haier

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Dometic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Helmer Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Eppendorf

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Meiling

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Felix Storch

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Follett

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Vestfrost

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Standex

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. SO-LOW

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Angelantoni Life Science

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. AUCMA

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Zkduling

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biomedical Cryopreservation Equipment Market

Figure 4: Global Biomedical Cryopreservation Equipment Market: Drivers

Figure 5: Global Biomedical Cryopreservation Equipment Market: Challenges

Figure 6: Global Biomedical Cryopreservation Equipment Market: Trends

Figure 7: Global Biomedical Cryopreservation Equipment Market: Opportunity

Figure 8: Global Biomedical Cryopreservation Equipment Market: Restraint

Figure 9: Global Biomedical Cryopreservation Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Biomedical Cryopreservation Equipment Market Value (USD Million) By Region

Figure 15: Global Biomedical Cryopreservation Equipment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Biomedical Cryopreservation Equipment Market Value (USD Million) By Region

Figure 23: Global Biomedical Cryopreservation Equipment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Biomedical Cryopreservation Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biomedical Cryopreservation Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Biomedical Cryopreservation Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Biomedical Cryopreservation Equipment Market Value (USD Million) By Region

Table 10: Global Biomedical Cryopreservation Equipment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Biomedical Cryopreservation Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Biomedical Cryopreservation Equipment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Biomedical Cryopreservation Equipment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Brooks Automation Basic Information And Sales Area

Table 31: Brooks Automation. Products Portfolio

Table 32: Panasonic Basic Information And Sales Area

Table 33: Panasonic. Products Portfolio

Table 34: Thermo Fisher Scientific Basic Information And Sales Area

Table 35: Thermo Fisher Scientific. Products Portfolio

Table 36: Haier Basic Information And Sales Area

Table 37: Haier. Products Portfolio

Table 38: Dometic Basic Information And Sales Area

Table 39: Dometic. Products Portfolio

Table 40: Helmer Scientific Basic Information And Sales Area

Table 41: Helmer Scientific. Products Portfolio

Table 42: Eppendorf Basic Information And Sales Area

Table 43: Eppendorf. Products Portfolio

Table 44: Meiling Basic Information And Sales Area

Table 45: Meiling. Products Portfolio

Table 46: Felix Storch Basic Information And Sales Area

Table 47: Felix Storch. Products Portfolio

Table 48: Follett Basic Information And Sales Area

Table 49: Follett. Products Portfolio

Table 50: Vestfrost Basic Information And Sales Area

Table 51: Vestfrost. Products Portfolio

Table 52: Standex Basic Information And Sales Area

Table 53: Standex. Products Portfolio

Table 54: SO-LOW Basic Information And Sales Area

Table 55: SO-LOW. Products Portfolio

Table 56: Angelantoni Life Science Basic Information And Sales Area

Table 57: Angelantoni Life Science. Products Portfolio

Table 58: AUCMA Basic Information And Sales Area

Table 59: AUCMA. Products Portfolio

Table 60: Zkduling Basic Information And Sales Area

Table 61: Zkduling. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Biomedical Cryopreservation Equipment Market Value (USD Million) By Region

Table 67: Global Biomedical Cryopreservation Equipment Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

FAQs

1. What is the current Biomedical Cryopreservation Equipment market size?

Approximately USD 1.25 billion in 2023, reflecting combined revenue from ultra‑low temperature freezers, liquid nitrogen storage tanks, and automated sample handling systems across clinical, research, and biopharma sectors worldwide, with an estimated annual growth of 5.3% and increasing demand for cell‑based therapies.

2. What is the projected growth forecast for the market through 2032?

Analysts project the market will reach USD 2.1 billion by 2032, driven by a compound annual growth rate of roughly 5.2% from 2024 to 2032, as biobanking expands and personalized medicine gains traction globally, particularly in emerging economies investing in genomic research.

3. Which factors are the key drivers behind market expansion?

Rising demand for cell and gene therapies, increasing biobank repositories, stricter sample integrity standards, and expanding vaccine production are primary drivers. Additionally, advances in automation and IoT‑enabled monitoring reduce loss risk, encouraging higher capital allocation.

4. What challenges could hinder market growth?

High acquisition costs, complex maintenance requirements, and limited skilled personnel for cryogenic systems pose barriers. Moreover, regulatory variability across regions and concerns over energy consumption in ultra‑low temperature units can slow adoption in cost‑sensitive facilities.

5. Which regions lead the Biomedical Cryopreservation Equipment market?

North America remains the largest contributor, driven by robust R&D spending and mature biotech ecosystems. Europe follows closely, while Asia‑Pacific shows the fastest CAGR, propelled by rapid biobank development in China, Japan, and South Korea.

6. Who are the top companies operating in this market?

Leading players include Thermo Fisher Scientific, Panasonic Healthcare, Haier Biomedical, Cryoport, and Chart Biomedical. These firms differentiate through integrated cold‑chain solutions, proprietary temperature‑control algorithms, and extensive service networks that address global compliance requirements, while also investing in next‑generation cryogenic technologies.

7. What future opportunities are emerging for the market?

Expansion of organ‑preservation platforms, growth of decentralized clinical trials, and integration of AI‑driven predictive maintenance create new revenue streams. Additionally, partnerships with regenerative‑medicine startups open niche applications for ultra‑low temperature storage, especially in personalized cell‑therapy pipelines requiring long‑term viability.

8. How is technology influencing the market’s future outlook?

IoT sensors, cloud‑based monitoring, and machine‑learning analytics enable real‑time temperature verification and predictive failure alerts, reducing product loss. These technologies improve compliance reporting and lower total cost of ownership, strengthening the market’s future outlook and fostering greater investor confidence.

9. What is the regulatory landscape governing Cryopreservation equipment?

Devices must comply with ISO 13485 quality‑management standards, FDA 21 CFR Part 820 for US manufacturers, and EU MDR for European distribution. Emerging guidelines on energy efficiency and environmental impact are also shaping procurement policies worldwide.

Contact for Full Report

Loading report content...

Biomedical Cryopreservation Equipment Industry Size, Share & Growth Forecast 2033

Market Snapshot

Biomedical Cryopreservation Equipment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Biomedical Cryopreservation Equipment Segmentation

Biomedical Cryopreservation Equipment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Biomedical Cryopreservation Equipment market size?

2. What is the projected growth forecast for the market through 2032?

3. Which factors are the key drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Biomedical Cryopreservation Equipment market?

6. Who are the top companies operating in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing the market’s future outlook?

9. What is the regulatory landscape governing Cryopreservation equipment?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Biomedical Cryopreservation Equipment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Biomedical Cryopreservation Equipment Segmentation

Biomedical Cryopreservation Equipment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Biomedical Cryopreservation Equipment market size?

2. What is the projected growth forecast for the market through 2032?

3. Which factors are the key drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Biomedical Cryopreservation Equipment market?

6. Who are the top companies operating in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing the market’s future outlook?

9. What is the regulatory landscape governing Cryopreservation equipment?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation